Vitamin D and type 2 diabetes: a systematic review
Tóm tắt
Từ khóa
Tài liệu tham khảo
Anderson JL, May HT, Horne BD, Bair TL, Hall NL, Carlquist JF et al. (2010). Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol 106, 963–968.
Avenell A, Cook JA, MacLennan GS, McPherson GC (2009). Vitamin D supplementation and type 2 diabetes: a substudy of a randomised placebo-controlled trial in older people (RECORD trial, ISRCTN 51647438). Age Ageing 38, 606–609.
Campbell IT, Jarrett RJ, Keen H (1975). Diurnal and seasonal variation in oral glucose tolerance: studies in the Antarctic. Diabetologia 11, 139–145.
Dawson-Hughes B, Harris SS (2010). High-dose vitamin D supplementation: too much of a good thing? Jama 303, 1861–1862.
de Boer IH, Tinker LF, Connelly S, Curb JD, Howard BV, Kestenbaum B et al. (2008). Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women's Health Initiative. Diabetes Care 31, 701–707.
Forouhi NG, Luan J, Cooper A, Boucher BJ, Wareham NJ (2008). Baseline serum 25-hydroxy vitamin d is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990–2000. Diabetes 57, 2619–2625.
Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003). Measuring inconsistency in meta-analyses. Bmj 327, 557–560.
Holden JM, Lemar LE (2008). Assessing vitamin D contents in foods and supplements: challenges and needs. Am J Clin Nutr 88, 551S–553S.
Hsia J, Heiss G, Ren H, Allison M, Dolan NC, Greenland P et al. (2007). Calcium/vitamin D supplementation and cardiovascular events. Circulation 115, 846–854.
Jorde R, Figenschau Y (2009). Supplementation with cholecalciferol does not improve glycaemic control in diabetic subjects with normal serum 25-hydroxyvitamin D levels. Eur J Nutr 48, 349–354.
Jorde R, Sneve M, Torjesen P, Figenschau Y (2010a). No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D3 for 1 year. J Intern Med 267, 462–472.
Jorde R, Sneve M, Torjesen PA, Figenschau Y, Goransson LG, Omdal R (2010b). No effect of supplementation with cholecalciferol on cytokines and markers of inflammation in overweight and obese subjects. Cytokine 50, 175–180.
Kirii K, Mizoue T, Iso H, Takahashi Y, Kato M, Inoue M et al. (2009). Calcium, vitamin D and dairy intake in relation to type 2 diabetes risk in a Japanese cohort. Diabetologia 52, 2542–2550.
Knekt P, Laaksonen M, Mattila C, Harkanen T, Marniemi J, Heliovaara M et al. (2008). Serum vitamin D and subsequent occurrence of type 2 diabetes. Epidemiology 19, 666–671.
Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA et al. (2002). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346, 393–403.
Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP (2007). Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 85, 1586–1591.
Lichtenstein AH, Yetley EA, Lau J (2008). Application of systematic review methodology to the field of nutrition. J Nutr 138, 2297–2306.
Liu E, Meigs JB, Pittas AG, Economos CD, McKeown NM, Booth SL et al. (2010). Predicted 25-hydroxyvitamin D score and incident type 2 diabetes in the Framingham Offspring Study. Am J Clin Nutr 91, 1627–1633.
Liu S, Song Y, Ford ES, Manson JE, Buring JE, Ridker PM (2005). Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older US women. Diabetes Care 28, 2926–2932.
Mattila C, Knekt P, Mannisto S, Rissanen H, Laaksonen MA, Montonen J et al. (2007). Serum 25-hydroxyvitamin D concentration and subsequent risk of type 2 diabetes. Diabetes Care 30, 2569–2570.
Moher D, Schulz KF, Altman D (2001). The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Jama 285, 1987–1991.
Nagpal J, Pande JN, Bhartia A (2009). A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men. Diabet Med 26, 19–27.
Narayan KM, Boyle JP, Geiss LS, Saaddine JB, Thompson TJ (2006). Impact of recent increase in incidence on future diabetes burden: US. Diabetes Care 29, 2114–2116.
Nilas L, Christiansen C (1984). Treatment with vitamin D or its analogues does not change body weight or blood glucose level in postmenopausal women. Int J Obes 8, 407–411.
Pittas AG, Dawson-Hughes B, Li T, Van Dam RM, Willett WC, Manson JE et al. (2006). Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 29, 650–656.
Pittas AG, Harris SS, Stark PC, Dawson-Hughes B (2007a). The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care 30, 980–986.
Pittas AG, Lau J, Hu FB, Dawson-Hughes B (2007b). The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 92, 2017–2029.
Pittas AG, Sun Q, Manson JE, Dawson-Hughes B, Hu FB (2010). Plasma 25-hydroxyvitamin D concentration and risk of incident type 2 diabetes in women. Diabetes Care 33, 2021–2023.
Prentice A, Goldberg GR, Schoenmakers I (2008). Vitamin D across the lifecycle: physiology and biomarkers. Am J Clin Nutr 88, 500S–506S.
Sanders KM, Stuart AL, Williamson EJ, Simpson JA, Kotowicz MA, Young D et al. (2010). Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. Jama 303, 1815–1822.
Sugden JA, Davies JI, Witham MD, Morris AD, Struthers AD (2008). Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels. Diabet Med 25, 320–325.
von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP (2007). The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med 147, 573–577.
von Hurst PR, Stonehouse W, Coad J (2010). Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient - a randomised, placebo-controlled trial. Br J Nutr 103, 549–555.
Wild S, Roglic G, Green A, Sicree R, King H (2004). Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27, 1047–1053.
Witham MD, Dove FJ, Dryburgh M, Sugden JA, Morris AD, Struthers AD (2010). The effect of different doses of vitamin D(3) on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial. Diabetologia 53, 2112–2119.